Top 10 proteincentre.com Competitors

food.au.dk

Professor, Science Team Leader at Department of Food Science - Food Quality Perception & Society at Aarhus University. See areas of expertise, research projects and contact information.

pfind.ict.ac.cn

pfind studio: a computational solution for mass spectrometry-based proteomics. pfind是目前国内唯一的具有自主知识产权的蛋白质鉴定引擎。我们是中科院计算所pfind团队，开发了蛋白质鉴定引擎pfind，以及一系列质谱数据分析软件。我们最近在nature methods期刊上发表了文章，这是国内蛋白质组学第一篇。

proteomics.com.au

Jordana Sheahan, Iris Wang, Peter Galettis, Scott Bringans, David Watson, Kirsten Peters, Richard Lipscombe Diseases of the Esophagus, Volume 38, Issue Supplement_1, August 2025, doaf061.017, https://doi.org/10.1093/dote/doaf061.017 Published: 14 August 2025 Abstract Background: Esophageal adenocarcinoma (EAC) is often diagnosed at an advanced stage, leading to poor prognosis. The current standard of care involves endoscopy with biopsy in at-risk populations, which is invasive and expensive, yet increasing endoscopic surveillance programs have failed to significantly reduce EAC mortality. Significant to patient management, the pre-cancerous condition Barrett’s Esophagus with high grade dysplasia (BE-HGD) is often treated promptly upon detection similarly to early stage EAC. This study evaluates an alternative diagnostic strategy using the blood test Promarker®Eso, a previously validated serum glycoprotein biomarker panel for EAC, to detect EAC from stage I-IV and BE-HGD. Methods: The study analysed 350 people across two independent cohorts: cohort A compared 89 healthy controls with EAC samples of known stage (I: n = 16, II: n = 23, III: n = 16, IV: n = 3); cohort B compared 40 negative controls with unstaged EAC (n = 48) with n = 115 BE samples. The multivariate PromarkerEso test measures four glycoprotein biomarker concentrations (alpha-1-antitrypsin, alpha-1-antichymotrypsin, complement C9 and plasma kallikrein) using a lectin-based magnetic bead array pulldown method with targeted mass spectrometry, combined with simple clinical data (age, sex, BMI). Samples are categorised by predicted probability scores as low- (75%) risk of having EAC. Results: PromarkerEso exhibited robust discrimination performance for all stages of EAC with a minimum area under the curve (AUC) of 0.97. Concurrently, the test exhibited high sensitivity for EAC in all stages (I: 81%, II: 91%, III: 100%; IV: 100%) and also for BE-HGD (93%). Additionall

sbw.fi

lue lisää yritysmuodoista ja niiden liiketoiminnoista. selvitä, mitä he tekevät ja mikä tekee heidän palveluistaan ja tuotteistaan erityisiä.

caprotec.com

charles river provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.

proteinmetrics.com

protein metrics provides comprehensive, vendor-neutral mass spectrometry data analysis software for protein characterization, quantification and identification

matrixscience.com

mascot software from matrix science - identification, characterisation and quantitation of proteins using mass spectrometry data